Methylation subgroup and molecular heterogeneity is a hallmark of glioblastoma: implications for biopsy targeting, classification and therapy

por Gempt, J., Withake, F., Aftahy, A.K., Meyer, H.S., Barz, M., Delbridge, C., Liesche-Starnecker, F., Prokop, G., Pfarr, N., Schlegel, J., Meyer, B., Zimmer, C., Menze, B.H., Wiestler, B.
Publicado 2022